Loss of PRDX1 increases RAD51 Cys319 oxidation and decreases homologous recombination

被引:0
|
作者
Skoko, John [1 ]
Asan, Alp [1 ]
Woodcock, Chen [1 ]
Cao, Juxiang [2 ]
Gaboriau, David [3 ]
Paulsen, Candice [4 ]
Attar, Myriam [1 ]
Wingert, Bentley [1 ]
Woodcock, Steven [1 ]
Schulte, Jennifer [2 ]
Ma, Hongqiang [1 ]
Camacho, Carlos [1 ]
Liu, Yang [1 ]
Morrison, Ciaran [5 ]
Carroll, Kate [4 ]
Freeman, Bruce [1 ]
Neumann, Carola [1 ]
机构
[1] Univ Pittsburgh, Pittsburgh, PA 15260 USA
[2] Med Univ South Carolina, Charleston, SC 29425 USA
[3] Imperial Coll London, London, England
[4] Scripps Res Inst, La Jolla, CA 92037 USA
[5] Natl Univ Ireland Galway, Galway, Ireland
关键词
D O I
10.1016/j.freeradbiomed.2018.10.159
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
155
引用
收藏
页码:S73 / S74
页数:2
相关论文
共 45 条
  • [31] Inhibition of homologous recombination by treatment with BVDU (brivudin) or by RAD51 silencing increases chromosomal damage induced by bleomycin in mismatch repair-deficient tumour cells
    Vernole, Patrizia
    Muzi, Alessia
    Volpi, Antonio
    Dorio, Annalisa S.
    Terrinoni, Alessandro
    Shah, Girish M.
    Graziani, Grazia
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2009, 664 (1-2) : 39 - 47
  • [32] MUTANT IDH1-DRIVEN CELLULAR TRANSFORMATION INCREASES RAD51-MEDIATED HOMOLOGOUS RECOMBINATION AND TEMOZOLOMIDE RESISTANCE
    Ohba, Shigeo
    Mukherjee, Joydeep
    See, Wendy
    Pieper, Russell
    NEURO-ONCOLOGY, 2014, 16
  • [33] Mutant IDH1-Driven Cellular Transformation Increases RAD51-Mediated Homologous Recombination and Temozolomide Resistance
    Ohba, Shigeo
    Mukherjee, Joydeep
    See, Wendy L.
    Pieper, Russell O.
    CANCER RESEARCH, 2014, 74 (17) : 4836 - 4844
  • [34] "Bridging the DNA divide": Understanding the interplay between replication- gaps and homologous recombination proteins RAD51 and BRCA1/2
    Ramirez-Otero, Miguel Angel
    Costanzo, Vincenzo
    DNA REPAIR, 2024, 141
  • [35] Estrogen Receptor β-Mediated Nuclear Interaction Between IRS-1 and Rad51 Inhibits Homologous Recombination Directed DNA Repair in Medulloblastoma
    Urbanska, Katarzyna
    Pannizzo, Paola
    Lassak, Adam
    Gualco, Elisa
    Surmacz, Eva
    Croul, Sidney
    Del Valle, Luis
    Khalili, Kamel
    Reiss, Krzysztof
    JOURNAL OF CELLULAR PHYSIOLOGY, 2009, 219 (02) : 392 - 401
  • [36] Role of the insulin-like growth factor I insulin receptor substrate 1 axis in Rad51 trafficking and DNA repair by homologous recombination
    Trojanek, J
    Ho, T
    Del Valle, L
    Nowicki, M
    Wang, JY
    Lassak, A
    Peruzzi, F
    Khalili, K
    Skorski, T
    Reiss, K
    MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (21) : 7510 - 7524
  • [37] Rad18 Regulates BRCA2, FANCD2, and Rad51 to Repair Topoisomerase 1 Inhibitor-Induced DNA Lesions through Homologous Recombination
    Palle, Komaraiah
    Tripathi, Kaushlendra
    Clark, David W.
    Mani, Chinnadurai
    FASEB JOURNAL, 2016, 30
  • [38] MUTANT IDH1-DRIVEN CELLULAR TRANSFORMATION INCREASES RAD51-MEDIATED HOMOLOGOUS RECOMBINATION AND TEMOZOLOMIDE (TMZ) RESISTANCE.
    Pieper, Russell O.
    Ohba, Shigeo
    Mukherjee, Joydeep
    NEURO-ONCOLOGY, 2014, 16
  • [39] Repression of LSD1 potentiates homologous recombination-proficient ovarian cancer to PARP inhibitors through down-regulation of BRCA1/2 and RAD51
    Tao, Lei
    Zhou, Yue
    Pan, Xiangyu
    Luo, Yuan
    Qiu, Jiahao
    Zhou, Xia
    Chen, Zhiqian
    Li, Yan
    Xu, Lian
    Zhou, Yang
    Zuo, Zeping
    Liu, Chunqi
    Wang, Liang
    Liu, Xiaocong
    Tian, Xinyu
    Su, Na
    Yang, Zhengnan
    Zhang, Yu
    Gou, Kun
    Sang, Na
    Liu, Huan
    Zou, Jiao
    Xiao, Yuzhou
    Zhong, Xi
    Xu, Jing
    Yang, Xinyu
    Xiao, Kai
    Liu, Yanyang
    Yang, Shengyong
    Peng, Yong
    Han, Junhong
    Cen, Xiaobo
    Zhao, Yinglan
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [40] Repression of LSD1 sensitizes homologous recombination-proficient ovarian cancer to PARP inhibitors through down-regulation of BRCA1/2 and RAD51
    Tao, Lei
    Zhou, Yue
    Luo, Yuan
    Zhao, Yinglan
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 427 - 429